A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia
Status:
Terminated
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
It is a normal process in the human body for red blood cells to die, which makes bilirubin.
Bilirubin is cleared away through the liver.
Some babies are born with livers that don't work well enough yet, or their red blood cells
are dying too fast, so the baby looks yellow (jaundice).
This means there is too much bilirubin in the body. It can be dangerous if a baby's bilirubin
gets too high.
Phototherapy is what they call the lights they shine on newborn babies to help the liver get
rid of bilirubin.
This study tests an experimental drug to see if it can reduce how much bilirubin is being
made in the first place.
Phase:
Phase 2
Details
Lead Sponsor:
InfaCare Pharmaceuticals Corporation InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company